Yehuda Handelsman to Adamantane
This is a "connection" page, showing publications Yehuda Handelsman has written about Adamantane.
Connection Strength
0.619
-
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab. 2019 04; 21(4):883-892.
Score: 0.619